1. Home
  2. BPMC vs JXN Comparison

BPMC vs JXN Comparison

Compare BPMC & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • JXN
  • Stock Information
  • Founded
  • BPMC 2008
  • JXN 1961
  • Country
  • BPMC United States
  • JXN United States
  • Employees
  • BPMC N/A
  • JXN N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • JXN Life Insurance
  • Sector
  • BPMC Health Care
  • JXN Finance
  • Exchange
  • BPMC Nasdaq
  • JXN Nasdaq
  • Market Cap
  • BPMC 5.8B
  • JXN 6.2B
  • IPO Year
  • BPMC 2015
  • JXN N/A
  • Fundamental
  • Price
  • BPMC $88.51
  • JXN $83.77
  • Analyst Decision
  • BPMC Buy
  • JXN Hold
  • Analyst Count
  • BPMC 22
  • JXN 5
  • Target Price
  • BPMC $124.29
  • JXN $97.40
  • AVG Volume (30 Days)
  • BPMC 958.8K
  • JXN 1.3M
  • Earning Date
  • BPMC 05-01-2025
  • JXN 05-07-2025
  • Dividend Yield
  • BPMC N/A
  • JXN 3.85%
  • EPS Growth
  • BPMC N/A
  • JXN 9.11
  • EPS
  • BPMC N/A
  • JXN 11.74
  • Revenue
  • BPMC $508,824,000.00
  • JXN $3,350,000,000.00
  • Revenue This Year
  • BPMC $45.43
  • JXN $116.51
  • Revenue Next Year
  • BPMC $32.80
  • JXN $1.32
  • P/E Ratio
  • BPMC N/A
  • JXN $7.08
  • Revenue Growth
  • BPMC 104.04
  • JXN 8.66
  • 52 Week Low
  • BPMC $80.68
  • JXN $62.81
  • 52 Week High
  • BPMC $121.90
  • JXN $115.22
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 43.04
  • JXN 45.30
  • Support Level
  • BPMC $86.99
  • JXN $82.43
  • Resistance Level
  • BPMC $93.04
  • JXN $90.33
  • Average True Range (ATR)
  • BPMC 3.36
  • JXN 3.35
  • MACD
  • BPMC 0.32
  • JXN 0.34
  • Stochastic Oscillator
  • BPMC 29.62
  • JXN 43.79

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

Share on Social Networks: